Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial

Radiotherapy and Oncology

Volumn 108, Issue 1, 2013, Pages 48-54

  Wolff, Hendrik Andreas ^a   Conradi, Lena Christin ^a   Beissbarth, Tim ^a   Leha, Andreas ^a   Hohenberger, Werner ^b   Merkel, Susanne ^b   Fietkau, Rainer ^b   Raab, Hans Rudolf ^c   Tschmelitsch, Jörg ^d   Hess, Clemens Friedrich ^a   Becker, Heinz ^a   Wittekind, Christian ^e   Sauer, Rolf ^b   Rödel, Claus ^f   Liersch, Torsten ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d KH D Barmh Brüder   (Austria)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

Gender; Multimodal treatment; Radiochemotherapy; Rectal cancer; Treatment associated toxicity

Indexed keywords

FLUOROURACIL;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLADDER INJURY; BLOOD TOXICITY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTESTINE INJURY; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CARCINOMA; SEX DIFFERENCE; SKIN TOXICITY; SURVIVAL RATE; THROMBOCYTOPENIA;

GENDER; MULTIMODAL TREATMENT; RADIOCHEMOTHERAPY; RECTAL CANCER; TREATMENT ASSOCIATED TOXICITY;

ADULT; AGE FACTORS; AGED; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; SEX FACTORS; TIME FACTORS;

EID: 84883195704     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.05.009     Document Type: Article

References (43)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. J.K. MacFarlane, R.D. Ryall, and R.J. Heald Mesorectal excision for rectal cancer Lancet 341 1993 457 460
4. Gastrointestinal Tumor Study Group Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum J Clin Oncol 10 1992 549 557
5. J.E. Krook, C.G. Moertel, and L.L. Gunderson Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 1991 709 715
6. R. Sauer, R. Fietkau, and C. Wittekind Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94 Colorectal Dis 5 2003 406 415
7. R. Sauer, T. Liersch, and S. Merkel Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 2012 1926 1933
8. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
9. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
10. I.J. Park, Y.N. You, and A. Agarwal Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 2012 1770 1776
11. Y.J. Chua, Y. Barbachano, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial Lancet Oncol 11 2010 241 248
12. C. Fernandez-Martos, C. Pericay, and J. Aparicio Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study J Clin Oncol 28 2010 859 865
13. C. Aschele, L. Cionini, and S. Lonardi Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 2011 2773 2780
14. A. Dewdney, D. Cunningham, and J. Tabernero Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) J Clin Oncol 30 2012 1620 1627
15. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
16. C. Roedel, T. Liersch, and H. Becker Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 2012 679 687
17. M.S. Roh, G.A. Yothers, and M.J. O'Connell The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 J Clin Oncol 29 2011 Suppl; abstr 3503
18. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer J Clin Oncol 28 10 2012 1638 1644
19. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
20. H.T. Eich, A. Stepien, and C. Zimmermann Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer: prognostic significance of tumor regression Strahlenther Onkol 187 2011 225 230
21. C. Aschele, M.L. Friso, and S. Pucciarelli A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 2005 1140 1146
22. J.P. Machiels, L. Duck, and B. Honhon Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study Ann Oncol 16 2005 1898 1905
23. R. Fietkau, C. Rodel, and W. Hohenberger Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94 Int J Radiat Oncol Biol Phys 67 2007 1008 1019
24. B.M. Ghadimi, M. Grade, and M.J. Difilippantonio Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826 1838
25. T. Liersch, M. Grade, and J. Gaedcke Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence Cancer Genet Cytogenet 190 2009 57 65
26. H.A. Wolff, L.C. Conradi, and M. Schirmer Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer Oncologist 16 2011 621 631
27. M.H. Seegenschmiedt, and R. Sauer The systematics of acute and chronic radiation sequelae Strahlenther Onkol 169 1993 83 95
28. A. Trotti, R. Byhardt, and J. Stetz Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
29. H. Pichlmaier, D.K. Hossfeld, and R. Sauer Konsenus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon- und Rektumkarzinom vom 11. März 1994 Chirurg 65 1994 411 412
30. W. Schmiegel, A. Reinacher-Schick, and D. Arnold Update S3-guideline "colorectal cancer" 2008 Z Gastroenterol 46 2008 799 840
31. R Development Core Team, FfSC A language and environment for statistical computing 2011 http://www.R-project.org
32. O. Purim, N. Gordon, and B. Brenner Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome Med Sci Monit 19 2013 203 209
33. O. Dahl, A. Horn, and O. Mella Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 33 1994 409 413
34. H.A. Wolff, I. Raus, and K. Jung High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma Int J Radiat Oncol Biol Phys 79 2011 1467 1478
35. K. Yamashita, Y. Mikami, and M. Ikeda Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers Cancer Lett 188 2002 231 236
36. E. Gamelin, R. Delva, and J. Jacob Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer J Clin Oncol 26 2008 2099 2105
37. C. Rodel, R. Hofheinz, and T. Liersch Rectal cancer: state of the art in 2012 Curr Opin Oncol 24 2012 441 447
38. G. de Castro, I.M. Snitcovsky Jr., and E.M. Gebrium High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 264 2007 1475 1482
39. E.J. Franzmann, D.S. Lundy, A.A. Abitbol, and W.J. Goodwin Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer Head Neck 28 2006 663 670
40. K. Bujko, R. Glynne-Jones, and M. Bujko Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials Ann Oncol 21 2010 1743 1750
41. H. Vorwerk, R.M. Hermann, H. Christiansen, T. Liersch, C.F. Hess, and E. Weiss A special device (double-hole belly board) and optimal radiation technique to reduce testicular radiation exposure in radiotherapy of rectal cancer Radiother Oncol 84 2007 320 327
42. H.A. Wolff, D.M. Wagner, and L.C. Conradi Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications Radiother Oncol 102 2012 30 37
43. S. Hennies, H.A. Wolff, and K. Jung Testicular radiation dose after multimodal curative therapy for locally advanced rectal cancer. Influence on hormone levels, quality of life, and sexual functioning Strahlenther Onkol 188 2012 926 932